
Article réservé aux abonnés


EFSA has published its report on the year 2016 of monitoring results for residues of veterinary medicinal products and unauthorised substances in live animals and products of animal origin.
A total of 710839 samples were checked by 27 Member States. The non-compliance rate for 2016 was 0.31%, comparable to the previous 9 years (0.25% -0.37%).
The presence of unauthorised substances and residues of veterinary medicinal products in food is a risk factor for public health.
Three main EU texts govern the rules applicable to veterinary residues and prohibited substances:
– Regulation (EU) No 37/2010 sets maximum residue limits for veterinary medicinal products in food-producing animals and products of animal origin.
– Regulation No 396/2005 sets maximum residue limits for pesticides in food and feed of plant and animal origin.
– Directive 96/23/EC lays down measures for the monitoring of certain substances and residues thereof, mainly veterinary medicinal products, in live animals and animal products.
The products analysed for 2016 are as follows: cattle, pigs, sheep and goats, horses, poultry, rabbit, farmed game, game, aquaculture, milk, eggs and honey.
For Group A:
– No non-compliant samples were reported for stilbenes and their derivatives (A1)
– For antithyroid (A2) agents, 0.45% of samples were non-compliant.
– In the steroid group (A3), 0.09% of the samples were considered non-compliant (all for anabolic steroids).
– In the group of resorcylic acid lactones (A4), 0.14% of the samples were not compliant for zearalanone and its derivatives.
– Prohibited substances (A6) were found in 0.03% of the samples. The substances identified were chloramphenicol, nitroimidazoles and nitrofurans.
For Group B:
– For antibacterial agents (B1), 0.17% of samples were non-compliant.
– In group B2 (other veterinary drugs), the highest proportion of non-compliant samples was found for NSAIDs (0.25%).
You can consult the complete regulations at the attached link: Report for 2016
Our laboratory has recently developed an innovative method for the analysis of drug residues on a number of chemical families unrivalled in France.
The laboratory is thus able to detect and quantify a large list of drug residues using a high-performance HPLC-QTOF technique, supplemented with LC-MS/MS, in a package that also includes Chloramphenicol.
For any technical, pricing or regulatory information, do not hesitate to contact us.